George Abongomera (MD, MSc, PhD) is a physician and researcher with several years of experience conducting clinical trials and implementating research in sub-Saharan Africa. He is currently working as a post-doctoral researcher in Global Health at the Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Switzerland.
Prior to moving to Switzerland, George was based at the Joint Clinical Research Centre in Kampala, Uganda, where he was involved in infectious diseases treatment and clinical trials, dealing with HIV/AIDS and TB in particular. He also coordinated and implemented a research project focusing on cost-effective and safe delivery of Antiretroviral Therapy to lower level rural health facilities in Uganda, Malawi and Zimbabwe. This research contributed significantly to his PhD work in Medical Sciences at the faculty of Medicine, University of Antwerp, Belgium.
Moherndran Archary is a Paediatric Infectious Disease Specialist in the Department of Paediatrics and Child Health at King Edward VIII Hospital affiliated to the Nelson R Mandela School of Medicine, University of KwaZulu-Natal. He is actively involved with the management of children and adolescents with HIV both locally and nationally within South Africa. His research interests include antiretroviral drug therapeutics, viral resistance and optimal timing of initiation of antiretroviral therapy in the developing world.
Dr. Alasdair Bamford is a consultant and specialty lead in paediatric infectious diseases at Great Ormond Street Hospital, London, UK and an Honorary Senior Lecturer at the Institute of Child Health, London, UK. He also works as a clinical advisor to paediatric clinical trials and cohort studies at the MRC clinical trials unit, London, UK. He has over 10 years of experience in working with children, adolescents and families affected by HIV. He is one of the lead authors for the Penta European guidelines for treatment of HIV infected children and a contributing author to the British HIV Association (BHIVA) guidelines on management of HIV in pregnancy. He is a member of the Penta Scientific Committee, the Collaborative HIV Paediatric Study (CHIPS) steering committee and UK National Study of HIV in Pregnancy and Childhood (NSHPC) steering committee. He is also treasurer of the British Paediatric Allergy Infection and Immunity Group (BPAIIG). He is a regular faculty member for both online and residential Penta courses on paediatric HIV in Europe, Africa and Russia.
David Burger received his Pharmacy Degree at the Utrecht University in 1990. He completed his PhD thesis, entitled “Bio-analysis and clinical pharmacokinetics of antiretroviral agents in HIV-infected individuals” at the Slotervaart Hospital, Amsterdam, in 1994. After this, he moved to the Radboud University Medical Centre, Nijmegen, for his hospital pharmacist training. From 1997 to 2005, he has been working as a hospital pharmacist responsible for the coordination of clinical trials conducted at the Radboud University Medical Centre. Since 1997 he has been leading a research group focussing on clinical pharmacology of antimicrobial agents with emphasis on HIV, TB, fungal infections, and HCV. He is member of the Editorial Board of the www.hiv-druginteractions.org and www.hep-druginteractions.org websites on behalf of the European AIDS Clinical Society. He is a member of the Organizing Committee of the annual International Workshop on Clinical Pharmacology of HIV/Hepatitis Therapy and is on the panel for HIV treatment guidelines of the IAS-USA. Since April 2011 he has been appointed as a Professor of Clinical Pharmacy at the Radboud University Nijmegen. He is (co-)author of more than 300 publications in this field. His topics of interest are drug-drug interactions, paediatric pharmacology, therapeutic drug monitoring, and operational research in resource-limited countries.
Mutsa Bwakura is a Consultant Paediatrician and Senior Lecturer within the department of Paediatrics and Child Health at the University of Zimbabwe College of Health Sciences. She has served as the project leader for the ARROW and REALITY clinical trials and is also affiliated to the IMPAACT network where she has been site Principal Investigator for a number of clinical trials in children including ART strategies for children who were exposed to nevirapine for PMTCT and those who were not. Mutsa is currently a Wellcome Trust Training Fellow where her research is focusing on the long term outcomes of severely malnourished HIV-infected and HIV-uninfected children following discharge from hospital.
• Director of the Center of Excellence for Children with Immunodeficiency (CENID) HIV / AIDS clinic of the National Children’s Hospital “Benjamín Bloom” El Salvador. Since July 2002
• President of the Pediatric Association of El Salvador (Asociación de Pediatría de El Salvador), 2017-2021
• Chair of the Board of Directors of the Children and Adolescents Hospital “Centro Pediatrico”, 2017-2019
• Vice-president of the Regional Committee for the Validation of the Elimination of Maternal-Infant Transmission of HIV and Congenital Syphilis of PAHO 2018-2019
• Coordinator of the Latin American Pediatric Latin American Network for Treatment of AIDS (PLANTA)
• Member of the HIV Technical Advisory Committee of El Salvador since 2004
• Member of the National HIV Pharmacovigilance Committee of El Salvador since 2010
• Member of the Technical Advisory Committee of PAHO on HIV and STIs since June 2012
• Member of the Technical Sub Commission of CONAVI (CONASIDA) since 2013
• Independent Consultant Member of the Regional Committee for the Validation of the Elimination of Maternal to child Transmission of HIV and Congenital Syphilis of PAHO, since May 2014
Collaborator on the following Texts:
• Clinical Guide and Formulary for the treatment of infectious diseases, PAHO-WHO 2005 Source: Washington DC Pan American Health Organization; 2005. 112 p. (OPS / HCP / HCT / 210/2005).
• National Guidelines for treatment for People Living with HIV / AIDS, publication of the National HIV / AIDS Program, Ministry of Health, El Salvador, November 2014.
• Guide for the Information System of HIV Post-Exposure Prophylaxis SIPPE, 2nd Edition, National HIV / AIDS Program, Ministry of Health, El Salvador, August 2004
• Antiretroviral treatment of HIV infection in children in Latin America and the Caribbean: on the road to universal access. Recommendations for a public health approach. “Pan American Health Organization Washington, D.C .: OPS © 2008. ISBN: 978-92-7-532859-0 (printed); 978-92-7-532860-6 (electronic)
Current Position: Chief of Vaccination unit – University-Hospital department, University of Tor Vergata and Paediatric hospital Bambino Gesù – Rome; Lecturer of infectious diseases at the Nursing School of Tor Vergata University – Rome; President of the Italian Society of Paediatric Infectious Diseases. Positions Held: Chief of Paediatrics in OPBG of Palidoro; Director of the Postgraduate school of Paediatrics – Bugando University College of Health Science Mwanza Tanzania; Researcher at Department of Paediatrics Univ. La Sapienza, Rome; Paediatric General Practitioner for Italian National Health System; Visiting scientist at the Immunology and Infectious Diseases Department at Paediatric Clinic in Miami, USA; Full time medical house officer and Responsible of AIDS Unit – Ospedale Pediatrico Bambino Gesù – Rome; Teacher of infectious diseases at the School of Specialization in Paediatrics of Tor Vergata University – Rome. Member of the Penta Scientific Committee; Member of the Steering Committee of the Italian Register for HIV infection in children.
He is the author and co-author of about 200 papers in National and International Scientific Journals.
Dr. Chishala Chabala is Paediatrician and Honorary Lecturer in the Department of Paediatrics and Child Health, at the University Teaching Hospital/University of Zambia, Lusaka, Zambia. He is currently the site principal investigator for the SHINE trial; a randomized controlled trial clinical trial of shorter treatment for children with minimal TB. Previously he was the site project leader for the CHAPAS 3 Trial that evaluated the pharmacokinetics, acceptability and adherence to fixed dose combination antiretroviral therapies for HIV-infected children in Zambia and Uganda conducted in 2010-2014. He has participated as a faculty member in Tr@inforPedHIV courses since 2011. He has vast clinical expertise in the management of HIV infection and tuberculosis in children.
Vira has been working as a paediatrician in the Infectious Diseases Centre “Clinic for treatment of children with HIV/AIDS” at the National Specialized Children’s Hospital “OKHMATDIT”, Kyiv, Ukraine since February 2008.
Her duties are the examination, treatment and management of children with HIV and their parents. At the same time, from 2009 to January 2016, she took part as an investigator in the clinical trials TMC114-TiDP29-C230, phase ІI and TMC114-TiDP29-C232. In the period from 2008 to 2010, as well as her work in the Clinic, she regularly went on working trips to different regions of Ukraine in order to consult with patients, monitor regional Centres for HIV/AIDS treatment. During the mentioned period, she also took part both in organizing and facilitating training programmes devoted to the problem of paediatric HIV for doctors, caregivers, and staff at orphanages.
From January to September 2017 she worked as a clinical advisor at the International training & education centre for health (I-TECH) / University of Washington in Ukraine under the international project “Strengthening Capacity of HIV/AIDS Treatment in Ukraine”.
Since 2008, Vira has regularly attended local and international conferences (including ESPID meetings), workshops, and training courses devoted HIV infections.
Since 2018 she has worked as a junior researcher at the Paediatric Department of the National Institute of Phthisiology and Pulmonology, named after F.G. Yanovsky NAMS of Ukraine. She has also participated in international studies in the PTBnet network.
Medical training at Facultad de Medicina, Buenos Aires University, training in adult Infectious Diseases at Hospital Muñiz, Buenos Aires. She was part of one of the 2 pioneer groups in taking care of the first cases of HIV patients and has been involved in numerous training programmes on HIV across the country. She is also head of the Haemophilic Cohort at the Haemophilia Foundation (established by. Dr. A. Pavlovsky), Haematology Research Institute, and National Medical Academy, taking care of HIV infection and co-morbidities until she left the country to continue related activities in Paris, France. There she works at the Neumology Department at Hôtel-Dieu Hospital, responsible for the follow-up and treatment of HIV patients.
Medical assistant at the Port Royal Maternity ward at the Cochin-Port Royal Hospital-University Group of the «Assistance Publique Hôpitaux de Paris», where she carries out follow-up care activity for pregnant women and others infected with HIV.
Medical coordinator, project manager of paediatric clinical studies at INSERM US019-SC10 (Therapeutic studies, HIV infection and Infectious diseases, National Institute of Health and Medical Research), France. Member of the Penta Scientific Committee, the teaching staff of the Tr@inforPedHIV programme through the Penta ID network and one of the leaders of this programme in Latin America, together with the Spanish and Latin American colleagues.
She was also member of the PDCO (Paediatric Committee) at the European Medicines Agency for 2 periods, between 2008-2016.
She is involved in many International paediatric projects that include sites in all continents, mainly focused on HIV in paediatrics.
Magda has worked with children, young people and families living with HIV for the last 17 years. For 5 years she was the UK policy lead and for the last 12 years she has worked as a freelancer for a number of organisations including the Children’s HIV Association, Medical Research Council, Penta and UNICEF for the CIS/CEE region, specialising in the psychosocial support for children with HIV, developing child-centred health practice and youth participation in clinical trials and research.
In this capacity she has managed a portfolio of work from direct support work with children and families through to delivering training programmes and developing national guidance and strategies. She has been part of the Penta faculty for many years, leading on youth and community engagement.
Since 2013 Magda has carried out work for UNICEF in the CIS/CEE region, developing training and resources to develop support provision for adolescents living with HIV and youth-friendly primary care. Prior to this, Magda worked with looked after children, ran community development projects and worked in HIV/sexual health promotion and teenage pregnancy reduction.
She has co-authored a number of publications, some of which include:
“Adolescents living with HIV: Developing and strengthening support services” Conway, M. Ely, A. (UNICEF, 2016)
“HIV in Schools: A guide to the pastoral care needs of children living with HIV.” Conway, M (NCB, 2005, updated 2015)
“Talking to children about their health diagnosis.” Donaghy, S. Melvin, D. Conway, M (CHIVA, 2010)
“Don’t forget the children. Guidance for the HIV testing of children of HIV positive parents.” Wood, C. Conway, M (Mediscript, 2009)
“Developing Support Services for Children, Young People and Families living with HIV.” Conway, M (NCB, 2006).
Dr Cotton is Head of Division of Paediatric Infectious Diseases and Director of the Family Infectious Diseases Clinical Research Unit at Tygerberg Children’s Hospital (TCH), Stellenbosch University (SU). He undertook a fellowship in paediatric infectious diseases at University of Colorado between 1991 and 1995. He is affiliated to the IMPAACT and Penta networks and provided technical support for WHO initiatives since 2004 on the Classification for HIV, antiretroviral guidelines and TB-HIV co-infection. He has experience in managing HIV-infected children. He is co-PI and investigator in several clinical trials in children, both on ART strategy (CHER). He is most interested in HIV cure and remission and how to do this in children. He is the principal investigator for the SU Clinical Trial Unit (SUN-CTU) with special focus on tuberculosis and HIV. He is involved in TB vaccine studies including a recombinant BCG vaccine. He has recently re-engaged in antimicrobial resistance, which is an expanding threat to children with fewer resources than the early years of the HIV pandemic.
Dr. Cressey (MSc, Ph.D) has been actively involved in HIV clinical research studies for over 15 years, primarily focused on mother and child health. Since completing his PhD in pharmacology at Newcastle University in the UK in 2001, he has been working as a researcher within the French National Research Institute for Development (IRD) research unit ‘Program for HIVPrevention and Treatment (PHPT)’ based at Chiang Mai University, Thailand. He also currently holds academic positions at the Harvard T.H. Chan School of Public Health, Boston, USA and the University of Liverpool, UK.
Dr. Cressey has performed multiple clinical pharmacokinetic studies aimed at optimizing antiretroviral drug dosing for adults, adolescents, children, pregnant women and newborns. Not only is he a long-standing member of the Penta training faculty, he is also an active member of the Penta ID network and has coordinated multiple Penta clinical trials in Thailand over the last 10 years. He is also working with the NIAID/NICHD-funded International Paediatric Maternal Adolescent AIDS Clinical Trials (IMPAACT) network in Thailand and is currently the co-chair of the World Health Organization (WHO) convened-Paediatric Antiretroviral Working Group (PAWG).
To support both investigator-initiated and network studies undertaken in Thailand, he has established a pharmacology laboratory at the Faculty of Associated Medical Sciences at Chiang Mai University. This laboratory contains state-of-the art equipment and is ISO 15189 and ISO 17089 accredited.
Marinella has worked as a Principal Investigator in over 40 Phase II, III and IV studies with children and adults infected with HIV since 1994, leading to extensive experience in clinical trials with new drugs and / or new treatments for HIV disease.
She was the president of an inpatient unit at the Institute of Infectious Diseases Emilio Ribas, a reference hospital for medical care, medical education and medical research for undergraduate, graduate and scholarship programmes.
She was a professor of Infectious Diseases at the School of Medical Sciences of Santa Casa de São Paulo, Brazil, one of the three best medical schools in São Paulo.
She has been president of an NGO called Association of Assistance to Children and Adolescents with HIV since 1989, and has the role of assisting children, adolescents and their families. This NGO is currently responsible for the financial support of adolescents who attend university or vocational courses and who adhere to antirretroviral treatment. She is a consultant of the HIV Advisory Committee of the Ministry of Health of Brazil.
Rashida Ferrand is an HIV clinical specialist and an epidemiologist. She is a Wellcome Trust Senior Clinical Fellow and a Professor of International Health at the London School of Hygiene and Tropical Medicine. She is based in Zimbabwe where she directs the Zim-LSHTM Research Partnership. Her research focuses on developing and evaluating strategies to improve outcomes across the HIV cascade in adolescents and young people. The other main area of Rashida’s research focus is the long-term chronic comorbidities associated with HIV infection among children growing up with HIV, specifically respiratory cardiac and musculoskeletal disease.
Dr. Caroline Foster is a Consultant in Adolescent HIV and Infectious Diseases at Imperial College Healthcare NHS Trust and is the clinical lead for transitional care in HIV. Current research studies include, the long term outcomes for adults born with HIV (bone health, malignancies, fertility) and characterisation of the latent reservoir in paediatric HIV. Research/education/guideline development and lecturing includes BHIVA, CHIVA, HYPNET, CHIPS/+, AALPHI, Penta, EPIICAL and UNICEF.
Anna Maria Geretti, MD, PhD, FRCPath, is Professor of Virology & Infectious Diseases and Honorary Consultant in Infectious Diseases. Having trained in Italy, the Netherlands and the United Kingdom, she is now based at the Institute of Infection & Global Health, University of Liverpool, where she consults on viral infections with focus on HIV and viral hepatitis, teaches and conducts research. Her research focuses on antiviral therapy, virus genetic diversity and diagnostics, and has led to over 200 publications. She is Secretary of the European AIDS Clinical Society. She contributes to policy formulation, education, and communication both nationally and internationally, and enthusiastically shares her expertise to train healthcare professionals and scientists.
Director of the Paediatric Infectious Diseases Unit at the Department of Woman’s and Child’s Health of the University of Padova.
Director of the Paediatric Infectious Diseases Unit at the Department of Woman’s and Child’s Health of the University of Padova. Member of the Italian National Committee for the fighta gainst AIDS and other infectious diseases, Ministry of Health (1998-2000).
WHO Consultant and advisor on several projects on paediatric HIV and paediatric care in developing countries (1989 ongoing).
Head of Penta since 1993, and President of the Penta Foundation since 2004.
Promoter and coordinator of “Tr@inforPedHIV”, a training program including distance and residential learning for developing countries (different funding sources including EU, Regional Gvts, UNICEF, private organisations, ESPID etc).
Honorary Senior Lecturer in the Centre for Paediatric Epidemiology and Biostatistics of the Institute of Child Health in London (2002-2010).
Chair of the Education Committee of the European Society Paediatric Infectious Disease (ESPID) (2006-2010).
Member of the Scientific Committee and of the Faculty of the “Diploma in Paediatric Infectious Disease” – University of Oxford, UK (2008 ongoing).
Consultant at the Ospedale Pediatrico Bambino Gesu’, City of Vatican, Rome (2010 ongoing).
Chief of the Paediatric Clinical Research and Trials Unit of the Azienda Ospedaliera/University of Padova (2011-2014).
Professor Gibb is a Professor of Epidemiology and Programme Leader of the Paediatric Programme of trials and cohorts at the MRC Clinical Trials Unit at UCL as well as Honorary Consultant Paediatrician at Great Ormond Street Hospital. Over the last 30 years she set up and coordinated a network of clinical trials and cohorts, across Europe, Thailand and South America mainly addressing questions in paediatric HIV infection.
Since 1999 her focus has expanded to Africa where she runs large trials, addressing strategy questions in adult and paediatric HIV infection and more recently in tuberculosis, malaria, hepatitis C and antimicrobial resistance in children, collaborating widely with clinical and research centres in 6 countries in East and Southern Africa. Wide inter-disciplinary collaboration with health economists, pharmacologists, social and basic scientists and innovators in medicines for children are incorporated into her trial programmes.
Capacity development is an important feature of the overseas collaborations, including interactive courses in paediatric HIV, on-the-ground training in clinical trials and PhD mentorship. She serves on a number of WHO advisory and guideline committees and continues a clinical commitment at the HIV Family clinic at the Great Ormond Street Hospital for Children in London, which she started in 1991.
She is a highly experienced researcher in the field of paediatric HIV, and has over 200 publications in the field. She has initiated and led on organising Tr@inforPedHIV in African centres.
Dr Mary Hepburn trained first as a general practitioner, then as an obstetrician and gynaecologist. She established and, for 30 years until her retirement from clinical practice in 2014, was consultant in charge of the Glasgow Women’s Reproductive Health Service, (WRHS) a city wide service for women with social problems. WRHS was the regional service providing reproductive healthcare for women infected with or affected by blood borne viruses including HIV and HCV. Consequently for 30 years all pregnant HIV+ve women in West of Scotland (and many from other regions as well) were under her care. She supported colleagues in other centres nationally and internationally in the development of specialised services for women with social problems and contributed to professional and government strategic development, and development of undergraduate and postgraduate training. In 2015 she was awarded the title of ‘OBE’ for her work. She continues non-clinical work including training and support for service development nationally and internationally.
Nigel Klein a Professor and Consultant in Paediatric Infectious Diseases and Immunology at Great Ormond Street Children’s Hospital, London, and the Institute of Child Health, University College London. He trained at the University College London (UCL), obtaining degrees in Anatomy and in Medicine. He established and led the Infectious Diseases and Microbiology Unit at ICH until 2014 and established and led the Department of Infection at UCL for 5 years until 2008. He has been working in the fields of Infectious Diseases for many years and has a particular interest in Meningitis, Sepsis, Innate Immunity, premature labour and HIV. He has been a member of several boards including the Wellcome Trust Infection and Immunity Board, Chair of the Grants Panel for Meningitis UK, a member of the Meningitis Research Foundation Grants Panel and is now Chair of the Action Medical Research Panel. He served on the Malawi Wellcome Trust International Scientific Advisory Board and the MRC International Nutrition Group Scientific Advisory Board. He is a member of the Penta Immunology and Virology committee, and was a member of the Steering Group for the Technology Strategy Board’s Innovation Platform on the Detection and Identification of Infectious Agents (DIIA). He has published more than 300 papers, many in high impact journals. He has supervised more than 30 PhD students of which 16 have or are Clinical Fellows. He is currently on the Paediatric Medicines Expert Advisory Group of the Medicines and Healthcare Products Regulatory Agency. He has recently been appointed Lead for Maternal, Child and Adolescent Health at the newly created Wellcome Trust Unified Institute based in KwazuluNatal in South Africa.
I am a consultant in paediatric infectious diseases and clinical lead for the service at Imperial College Healthcare NHS Trust, London. Prevention of transmission of HIV from mother to infant, and management of HIV infected children and young people are my main areas of clinical work. I also look after children with other congenital infections (syphilis, toxoplasmosis, CMV etc) and work with the multidisciplinary team to promote their prevention. I run a weekly congenital infection clinic and am involved in setting up a European registry for congenital CMV infection. I am a member of the Penta Scientific Committee and participate in treatment trials for HIV infected children. I am passionate about sharing experience with clinical colleagues, and learning together about our patients’ conditions and how to care for them better.
In 2005, we initiated ‘Tr@inforPedHIV’, a unique online and residential course for paediatric HIV. Now called ‘PentaTr@ining’, this course has trained more than 4,000 healthcare workers around the world on the management of paediatric HIV. In 2020 we are fully updating and upgrading the online course to include other congenital infections as well as HIV, and we hope that the new fully case based modules will be highly user-friendly, and promote dialogue between tutors and delegates on the course. I look forward to meeting you all on the course.
– Head of Department: General Paediatrics, Infectious and Tropical Diseases-Vaccination at Universitary Hospital La Paz, Madrid. Spain. CSUR- National Reference Spanish Centre on Paediatric Tropical Diseases from Health Ministry
– Associate Professor of Madrid Autónoma University
– PI SERMAS-EPTRI: European Paediatric Translational Research Infrastructures (H2020-2018-2020)
– Penta Scientific Committee (FP.EU: Paediatric European Network for the Treatment of Aids): 1992-2019
– Penta-Teaching – TEAM y ESTHER-MSC: Coop. Internacional-Sida. A. Latina y Caribe: 2007-2019
– Steering Committee – TEDDY (FP-EU.Task Force Drug Development Young 2005-2010)
– Scientific Committee – TEDDY-EnprEMA: 2014-2019
– Researcher PENTI (Paediatric European Network for the Treatment of Infection) 2000-2019
– Co-coordinator – PENTA-vac: Europen Paediatric Vaccines Network in HIV-infected children
– Steering Committee – CoRISpe: Paediatric National Cohort-HIV infected-children. Red Ris: 2000-2019
– Scientific Committee – Biobank-Hospital General University Gregorio Marañón
– Member – Research Foundation Hospital Carlos III: 2008-20012
– Vice president – Resarch Foundation Paediatric Spanish Society on Infectious Diseases: 2010-2017
– GRiP member – Group Researching in Mother-child Health: 2010-2019
– pTBnet member – Paediatric Tuberculosis European Network: 2012-2019
– Coordinating Group pTBred; Spanish Network on Paediatric Tuberculosis: 2013-2019
– Coordinator´s RedGiP – Pediatric Spanish network on Giardiasis: 2015-2019.
– REDIVI Research; SpanishTravelers Children Network: 2016-2019
– RITIP Research: National Network on Traslational Paediatric Infectious Diseases: 2016-2019
– RECLIP – conect4children (c4c) Research: Spanish Network on Paediatric Clinical Trial included in c4c: 2016-19
– Expert in Paediatric Infectious Diseases EU nº ex: 2006c125903: since 2008
– Expert National-Paed Infectious Diseases – Ag Nacional Evaluación Prospectiva (ANEP): 2015-2017
– Coordination of Paediatric Medical Committee – Spanish Paediatric Society-AEP: 2010-2017.
– Expert in Paediatric Infectious Diseases – Agencia Española Medicamentos: PDCOO-AEMPS
– External Expert – Comité Asesor de Vacunas – Pediatric Spanish Society (CAV-AEP): 2019-2019
– Reviwer of Grants FISS. SNS. Research from Ministry of Health, Spain
– President of Spanish Paediatric Infectious Diseases Society (SEIP): 2008-2012
– Presidente de la Asociación Española de Pediatria (AEP): 2017-2019
– Grant Albert Jovell 2017: Best professional way linked to affectivity-humanity
– Principal Investigator: 11 Clinical Trials and 20 clinical studies. Research Collaborator: 10 Clinical Trials, 30 clinical studies
– 16 Research grants. Principal Investigator: 2 FISS, 1 Rio Hortega, 1 Juan Rodés. Research Collaborator on 3 H2020-EU projects
– Part of the teaching staff of the Paediatric European Network Treatment of AIDS (PENTA) “Tr@inforPedHIV” Programme for Latin America and the Caribbean (2008 – 2019)
– Consultant for National HIV Program, Ministry of Health (1998 – 2018)
– Responsible of the Component HIV AIDS in the Province of Guayas (2005)
– Coordinator of Prevention of Vertical Transmission of HIV at Guayas Province (2004 – 2006)
– Consultant in Infectious Disease and HIV, Guayas Province (2001, 2002, 2003, 2004)
PAHO Consultant and advisor on:
– Diarrhoeal Diseases and Cholera Control for Honduras (2004)
– Consultant for the Rational Pharmaceutical Management Plus – Management Sciences for Health (MSH) for the Regional Workshop: Therapeutic Guides to improve the Antimicrobial Use in Hospitals (2003)
– Past President of the Latin American Pediatric Infectious Disease Society (2009 – 2011)
– Member of the European Society Paediatric Infectious Disease (ESPID)
– Member of the Pediatric Infectious Disease Society of America
– Member of the Latin American Pediatric Infectious Disease Society
– She has been involved in International paediatric projects and research, including on the Zika virus
Gwamaka Mwasakifwa is an HIV physician and clinical researcher with over eight years of experience in HIV medicine, particularly adolescent HIV treatment. He is currently based at the Kirby Institute, University of New South Wales. His current research examines the use of biological markers in predicting HIV associated comorbidities in low and middle-income countries.
He has previously worked in HIV and TB care and treatment services in Tanzania, and Nepal. He has been involved in the Tr@inforPedHIV training courses since 2016. He has a keen interest in developing intelligent clinical tools, and innovative digital health solutions focused on improving patient experiences, quality of care, service delivery and strengthening global health systems.
Victor is a Senior Lecturer at Makerere University, College of Health Sciences, Department of Paediatrics and Child Health, in Kampala, Uganda; and an Investigator at Joint Clinical Research Centre (JCRC), Kampala, Uganda. He has worked as a Paediatrician at JCRC in HIV research, clinical care and treatment since 2004. He led a team of personnel that initiated and followed up a cohort of over 2000 HIV-infected children on antiretroviral therapy. He has also provided treatment for opportunistic infections, as well as other forms of comprehensive Paediatric HIV care and treatment. He has also been an investigator on several research protocols, including the: ARROW, CHAPAS 2, 3 and 4, BREATHER, REALITY and LIVING clinical trials. He is Programme Director for the Master of Medicine (MMed) course in the department of Paediatrics and Child health at Makerere University. His clinical and research interests are in Paediatric HIV infection and other infectious diseases, antiretroviral therapy and child nutrition.
Director, Centre for Child Health and Adolescence, HELIOS Klinikum Krefeld, Germany; Academic Hospital, RWTH Aachen;
1991 onwards Postdoctoral Fellow, Department of Molecular Medicine, North Shore University Hospital (NSUH), Cornell University New York;
1993 onwards Intern, Resident, Fellow, Registrar, Lecturer at University Children s Hospital Heinrich Heine University Düsseldorf;
1998 onwards Leading author of German National Guidelines on the Treatment of HIV infected Children;
2006 onwards Member of Penta Scientific Committee;
2007 onwards Director, Centre for Child Health and Adolescence, HELIOS Klinikum Krefeld, Germany;
2007 onwards Member of the German National Committee for Multiple Choice Questions in Medicine;
2008 onwards Professor of Paediatrics (Heinrich Heine University Düsseldorf);
2009 onwards; Co-author of Penta Guidelines for Treatment of children with HIV infection;
2010 onwards Speaker, Study Group Paediatric Immunology (AKPI) of the German Society of Immunology (DGfI);
2011 onwards Expert at the European Medicines Agency EMA, Special advisory group HIV, Virology;
2015 onwards Member Immunodeficiency Group. German National Committee on Vaccination/Ständige Impfkommission (STIKO) at Robert-Koch-Institut (RKI).
Antoni Noguera-Julian, MD, Phd, is a Consultant in Paediatric Infectious Diseases at Hospital Sant Joan de Déu in Barcelona (Spain). He is a Professor of Paediatrics at Universitat de Barcelona and coordinates the Master Course in Paediatric Health (Hospital de Nens, Universitat de Barcelona) as well. He graduated from the Universitat de Barcelona in 1997 and completed his internship and residency in Paediatrics at Hospital Sant Joan de Déu in 2003. Dr. Noguera-Julian´s areas of interest include: HIV and other vertically-transmitted infections and tuberculosis in the pediatric age
Dr. Noguera-Julian has been part of the Penta Scientific Committee since 2010 and has given lectures in several Penta training courses on HIV infection in children and adolescents in Latin America.
Liubov Okhonskaia, PhD, works as an Infectious Diseases consultant in the Republican Clinical Infectious Diseases Hospital of the Ministry of Health of Russia, Saint Petersburg, since 2011. Liubov has been teaching on Penta training courses in Eastern Europe and Central Asia since 2014 and has been one of the leading tutors on the online Russian course. Her current interests are HIV infection, HIV/TB coinfection and viral hepatitis in children and adults.
DPhil, University of Oxford (Paediatric HIV infection) 2005-2009; Academic Clinical Lecturer in Paediatric Infection and Immunity, University of Oxford, 2009-2011; Honorary Clinician Scientist, MRC Clinical Trials Unit at UCL, from 2009; Associate Faculty, Department of International Health, Johns Hopkins Bloomberg School of Public Health, from 2010; Senior Lecturer in Paediatric Infection and Immunity, Queen Mary University of London, from 2011; Honorary Consultant in Paediatric Infection and Immunity, Barts and the London Children’s Hospital, from 2011; Wellcome Trust Intermediate Clinical Fellow, based in Zimbabwe undertaking clinical HIV work and research, from 2011; Honorary Lecturer, Department of Paediatrics and Child Health, University of Zimbabwe, from 2012; Member of Guideline Committee, Children’s HIV Association of UK and Ireland, 2009-2011; 23 peer-reviewed publications on paediatric HIV, 2007-2011; Member of WHO Technical Reference Group on Paediatric ART/HIV Care, 2008-present; Member of Trial Management Group, ARROW Trial (HIV trial conducted in Uganda/ZImbabwe), 2009-present; Member of Endpoint Review Committee, ARROW Trial, 2009-present; Course Development Officer, Diploma in Paediatric Infectious Diseases, University of Oxford, 2010-present.
Pablo Rojo is a Paediatric Infectious Diseases Specialist working at Hospital 12 de Octubre, Madrid, Spain. He is also Associate Professor of Complutense University, Madrid, Spain. He obtained his MD and PhD from Complutense University.
He has been a member of the Board of the Spanish Society of Paediatric Infectious Diseases (SEIP) from 2010 to 2014 and member of the ESPID Research Masterclass Committee since 2013. He is author and co-author of over 80 peer reviewed scientific articles and book chapters. His main research activities are related to HIV, S. aureus and congenital CMV infection. Concerning Paediatric HIV, he is member of the Penta Scientific Committee and EPPICC Committee; he has participated in many clinical trials with antiretrovirals and is part of the EPIICAL project pursuing a therapeutic vaccine for HIV-infected children. He participates as a Technical advisor on Paediatric HIV for the Spanish Government, he participates in a collaborating project on Paediatric HIV in Equatorial Guinea and has also advised WHO in Paediatric HIV treatment. With regards to S. aureus, he is focused on community-acquired S. aureus infection and virulence factors, he is the principal investigator of the European Project on Pediatric Invasive S. aureus Infections. With respect to congenital CMV infection, he is a member of the Panel Group on congenital CMV of the Spanish Society of Paediatric Infectious Diseases and is co-coordinator of the Spanish Cohort of congenital CMV. He co-organizes an International meeting on congenital CMV infection every two years in Madrid, Spain.
Medicine degree: Universidad Complutense of Madrid, from 1977 until 1983. Specialization in Paediatrics. Hospital 12 de Octubre Madrid (1984-1988). Sub-speciality Infectious Diseases. Consultant in Paediatric Infectious diseases at the Section of Immunodeficiencies, Department of Paediatrics in Hospital 12 Octubre, Madrid until June 2006. Granted by the National Health System (FIS) at the Infectious Disease unit in St Jude Children’s Research Hospital, Memphis, Tennessee, June-October 1994. Head of Pediatrics University Hospital Getafe since July 2006. Degree in Medicine as Medical Doctor. Doctoral – thesis: Presented on October, 1993 at the Faculty of Medicine of the Complutense University of Madrid. Director of 7 doctoral thesis at the: University Complutense: Infectious Diseases-HIV. Associate Professor in Paediatrics at the Department of Paediatrics of the Complutense University of Madrid, since October 1998 to 2006. Accreditation by the National Agency of Quality and Accreditation (ANECA) for University Teaching Activities in 2011. Principal Investigator of 21 investigational projects, most on HIV-infection in children. Principal investigator of the Madrid cohort of HIV-infected children and the Madrid cohort of HIV infected mother-infant pairs. Author and co-author of 78 book chapters, and 214 publications until July 2011. Reviewer of several international and Spanish journals on Paediatrics and Infectious Diseases. Member of the Penta Scientific Committee since March 1998. Member of the Spanish Advisory Committee of Plan Nacional del SIDA (Ministry of Health) since November 2000.
Claire Thorne is a Professor of Infectious Disease Epidemiology in the Population, Policy and Practice Research and Teaching Department, UCL Institute of Child Health, University College London, UK. Claire’s research has focused on the epidemiology of viral infections with respect to maternal and child health, with a particular emphasis on HIV, viral hepatitis and Zika virus. Claire leads the UK and Ireland National Surveillance of HIV in Pregnancy and Childhood and hepatitis B and C surveillance and cohort studies in the UK and Ukraine, and co-leads the European Pregnancy and Paediatric HIV Cohort Collaboration and PENTAHep (an international paediatric HCV clinical network). She is a Board Member of the Penta Foundation; a member of the Scientific Committee of the Penta ID network; and an Advisory Board member of the International Antiretroviral Pregnancy Registry. Claire serves on technical working groups for WHO and UNICEF, and is a Member of Regional Committee for Validation of Elimination of MTCT of HIV and/or syphilis in the WHO Region. Member, Scientific Committee, International Workshop on HIV Pediatrics (2009-2019); Member of the International Advisory Board of Lancet HIV, Editorial Panel of Journal of Viral Eradication and Editorial Board of HIV Medicine. She teaches on the introduction to epidemiology and the immunisation and infectious diseases modules of the MSc in Paediatrics and Child Health at UCL and has extensive experience of supervising PhD and MSc students.
Gareth Tudor-Williams is a Professor of Paediatric Infectious Diseases at Imperial College London, and Consultant Paediatrician at Imperial College Healthcare NHS Trust (ICHT), St. Mary’s Hospital, London.
Career in paediatric infectious diseases was inspired by 2 years as Medical Officer, Save the Children Fund (UK) in Baglung, Nepal. Sub-specialisation in Paediatric HIV began in 1989 with 2 yrs Paed ID Fellowship at Duke University, N. Carolina. 3 yrs as Visiting Scientist/ Attending Paediatrician at National Institutes of Health, Bethesda, MD. Involved in Phase I, II, and III clinical trials for HIV infected children since 1989. Member of the Penta Scientific Committee since 1994. Principal Investigator for our site for numerous Penta trials. Founding chairman of the Children’s HIV Association of the UK and Ireland (CHIVA) in 2002. Co-Chief Investigator for PACTG390/PENPACT1 trial of treatment and switching strategies in HIV infected children, a trans-Atlantic collaboration [Lancet Infect Dis. 2011 Apr;11(4):273-283]. Co-founder, CHIVA-Africa programme. Clinical lead for trial of early therapy for infants in Durban, S. Africa (PEHSS study). Chair, Clinical Endpoint Review Committee for ARROW (1,200 HIV-infected children enrolled in Uganda and Zimbabwe). UK CI for trials of tenofovir paediatric formulation (Gilead), etravirine (TMC125 – Tibotec), and elvitegravir (Gilead) in HIV infected children. Chair, Data Monitoring Committee for PRINCE 1 and 2 atazanavir trials (BMS), and fosamprenavir trials (GSK). Member, DSMB for 13-valent pneumococcal vaccine studies in HIV infected children, then Chair DMC for multidose vaccine trial (Pfizer). Trial steering committee for NRTI-sparing trial (SMILE) 2017-. Paediatric Expert, London Central Research Ethics Committee, 2011-. Training Programme Director for academic trainees, London School of Paediatrics, 2014-18. Chair, Clinical Ethics Committee, ICHT 2016-. Advisor to WHO and UNICEF for Pakistan ‘outbreak’ in which more than 800 children have been newly diagnosed as HIV infected, 2019-.
Anna Turkova is a research clinician at the MRC CTU at UCL, London, and Penta and an Honorary Consultant Paediatrician at the Imperial College London Healthcare Trust and Great Ormond Street Hospital. She has been a member of the Penta Faculty since 2011, and has been teaching on Penta training courses in Eastern and Western Europe, Central Asia and Africa. She is jointly leading on-line Penta training and residential courses in Eastern Europe and Central Asia. Anna is one of the lead authors for updating Penta guidelines for treatment of paediatric HIV 2015-2016.
Prior coming to the UK in 2002, she worked for four years in Paediatric Infectious Diseases in Russia. In 2015 she was elected to the Executive Committee of the Children’s HIV Association (CHIVA), UK. She is a current chair of the CHIVA Guidelines Subcommittee. Anna is a member of the European Society for Paediatric Infectious Diseases (ESPID) and the Paediatric Tuberculosis Network European Trials group (pTBnet). Her special interests are HIV, co-infections, viral hepatitis and TB.
Dr. Marta Vasylyev is an infectious diseases consultant working at the HIV unit in Lviv Regional Public Health Centre, West Ukrainian Specialized Medical Children’s Centre, and Medical Centre “Astar” in Lviv, Ukraine. She was trained in leading hospitals in Dublin and Barcelona. She is a member of the European AIDS Clinical Society (EACS) guidelines Treatment Panel.
Her special interests are HIV, co-infections, viral hepatitis, and STDs in children and adults.
She has been a faculty member on Tr@inforPedHIV courses since 2018.
Alla is a Doctor of Medicine and Professor of Paediatric Infectious Diseases and Paediatric Immunology in Shupyk National Medical Academy of Postgraduate Education, Kiev. Since 1992 she has been working in the field of infectious diseases in children and congenital immunodeficiencies – since 2000 in the field of HIV. She is the author of 135 scientific papers, including 2 textbooks. She has trained in leading university hospitals in Canada, Israel, Austria. Consultant of Kyiv City HIV / AIDS Center. She is a member of paediatric societies ESPID (since 1997) and ESID (since 2002). Alla has been a lecturer on Penta courses on HIV infection since 2013. Priority areas of work: HIV infection, congenital immunodeficiency’s, vaccination.
Hylke finished his training as a pharmacist in February 2017 and is currently in his third year of a 4 year PhD trajectory in the research group of David Burger at the Radboud Institute for Health Sciences in Nijmegen, The Netherlands. His research focuses on the pharmacokinetics of antiretroviral drugs, specifically in HIV infected children. Currently, he is involved in the CHAPAS-4 and Odyssey projects. He has been involved in the Tr@inforPedHIV training courses since 2017.
His interests include: global health, pharmacokinetics (in paediatrics), and pharmacometrics.
– Training Lead for Penta since 2010, and for pTBnet since 2016
– Member of Penta Scientific Committee, 2009 onwards
– Member of CHIVA Guidelines Subcommittee, 2008 onwards
– Member of British HIV Association (BHIVA) Pregnancy Guideline Committee, 2011 onwards
– Chair, Children’s HIV Association of the UK and Ireland (CHIVA), 2011-2015
– Enjoys living quietly, gardening and walking his dog